Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-14T23:06:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision indicator changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-07T23:10:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error, replacing the previously visible study details with an error screen. This indicates that the study record content is no longer accessible due to a permissions issue.
    Difference
    21%
    Check dated 2026-09-23T23:06:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a newer release of the page content. This update appears to reflect internal updates or bug fixes rather than changes to the study details shown.
    Difference
    0.0%
    Check dated 2026-09-16T22:27:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.6, replacing the previous v3.6.5. The related topics section has been trimmed, removing items such as Lung cancer and MedlinePlus Genetics from the list.
    Difference
    0.2%
    Check dated 2026-09-02T19:38:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study record now lists related topics and indexing terms (Lung cancer, related topics:, MedlinePlus Genetics). This enhances discoverability without altering core study details.
    Difference
    0.1%
    Check dated 2026-08-19T13:32:08.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.